Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds
Novel Antifungal Agent Highly Active Against Esophageal Candidiasis
Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia
Cholesterol-Lowering Drugs May Prevent Breast Cancer
Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds
NCCN Updates Breast Cancer Guidelines for Patients
Lung Cancer Clinical Trials Cost-Effective Alternative
Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress
New Drug Reduces Nausea and Vomiting
Clinical Trials Approved By NCI
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Scaling excellence: How City of Hope is transforming cancer care delivery
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI
